Elisabetta Leo

Company: AstraZeneca

Job title: Principal Scientist - Associate Director

Seminars:

Panel Discussion: PARPi’s: The Whole Story? PARP & DDR Biomarkers, Targets & Hope in Indications Outside of Breast & Ovarian 9:30 am

Sharing insights into future directions and what to anticipate as standards evolve for PARP and other DDRi’s in the clinic How is it looking for prostate? leukemia? GBM? pancreatic? endometrial? SCLC? What are the differences between cancers in terms of resistance to PARP inhibitors? Thoughts on moving to a more genomic rather than indication-specific biomarker-driven…Read more

day: Day One

Progress in PARP1 Selective Inhibitors: AZD5305 8:30 am

Delve into discovery, development and validationRead more

day: Day One